Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence

DOI: 10.1038/npp.2017.245

Full-Text   Cite this paper   Add to My Lib

Abstract:

Correction to: Neuropsychopharmacology advance online publication, 27 September 2017; doi: 10.1038/npp.2017.20

Full-Text